"We advised manufacturers who want to update their COVID-19 vaccines to develop a modification that will include the Omicron BA.4/5 spike protein and that this variant of the booster vaccine will be available by mid-fall 2022," he said Dr. Peter Marks, director of the FDA's Biological Assessment and Research Center. The Advisory Committee on Vaccines and Associated Biological Products voted in favor of this recommendation, considering that such a vaccine would provide wider protection against the strains of the coronavirus that we are currently dealing with.
What's in the air?
According to the US Centers for Disease Control and Prevention (CDC), the United States currently has two Omicron sub-options: BA.4 and BA.5. Research suggests that...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
